Weill Cornell Medicine investigators have developed a technique to help surgeons reconstruct more natural-looking nipples for patients who have undergone breast reconstruction after mastectomy to treat breast cancer.
Compared with men, women continue to have a roughly 30-40% higher risk of dying following coronary artery bypass surgery, according to a large study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
A small but significant metabolic difference between human and mouse lung tumor cells has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results and pointing toward new strategies for developing cancer treatments.
Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute to investigate the molecular mechanisms by which immune cells interact with Epstein-Barr virus to cause lymphoma, particularly in people living with HIV.
An interdisciplinary collaboration used a materials science approach to “fingerprint” calcium mineral deposits that reveal pathological clues to the progression of breast cancer and potentially other diseases.
The size, strength and makeup of people’s social networks are key indicators of how they will respond to the health consequences of an environmental disaster, according to a new Cornell study that focused on the Flint, Michigan water crisis.
Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
A new screening tool identified roughly half of primary care patients with chronic obstructive pulmonary disorder who could benefit from available treatments, according to a nationwide study.
